SUN reported an EPS of LKR 0.61 (-14.8% YoY) for 3Q FY25 resulting a PATMI of LKR 1.2bn. The decline resulted mainly with the margin contraction in Consumer segment. Group turnover grew by 6.4% YoY to LKR 15.1bn driven by robust growth in the Healthcare segment. Group EBIT margin was sustained at 18.2% (vs previous 18.1%) as a result of the favourable margin movement in healthcare and agribusiness segments. We continue to remain bullish on SUN in the medium to long term, driven predominantly by the Healthcare segment. We believe robust performance of Agribusiness and recovery of Consumer segment will position SUN for long term growth. We maintain our BUY call with a TP of LKR 27.00 on SOTP valuation.